Similarly, a previous study from MD Anderson Cancer Center (MDACC) by Cabioglu et al. reported a high CXCR4 expression of 41% in distant metastatic sites, including bone, lung, liver, and brain of breast cancer patients [12]. Here, CXCR4 is linked to breast cancer.